• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IGHG1 在人类胰腺癌中的存在与免疫逃逸机制有关。

The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms.

机构信息

Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, PR China.

出版信息

Pancreas. 2011 Jul;40(5):753-61. doi: 10.1097/MPA.0b013e318213d51b.

DOI:10.1097/MPA.0b013e318213d51b
PMID:21654544
Abstract

OBJECTIVES

To investigate the expression of Igγ-1 chain C region (IGHG1) in human pancreatic carcinomas and determine the biological function of IGHG1 expression in immune evasion mechanisms.

METHODS

Comparative proteomic analysis was used to detect the differential expression of IGHG1 in human pancreatic cancer tissues versus adjacent noncancerous tissues, followed by confirmatory tests including quantitative real-time reverse transcription-polymerase chain reaction, Western blot analysis, immunohistochemistry, and immunofluorescence. A murine pancreatic tumor model was established by transplantation of IGHG1-overexpressing Panc02 cells. The cytotoxic responses of natural killer (NK) cells were assessed with a lactate dehydrogenase release assay.

RESULTS

Igγ-1 chain C region was found to be present in human pancreatic cancer tissues but nearly absent or expressed lower in adjacent noncancerous tissues. In the murine pancreatic tumor model, the tumor growth was significantly accelerated from day 12 to 20 after tumor injection, and the survival time of animals was decreased. Blockage of IGHG1 led to retarded tumor growth and improved survival. The cytotoxicity assay revealed that IGHG1 downregulated the cytotoxic activity of NK cells through inhibition of antibody-dependent cellular cytotoxicity function.

CONCLUSIONS

The presence of IGHG1 in pancreatic cancer cells might constitute an important element responsible for tumor cell proliferation and immune evasion mechanisms.

摘要

目的

研究 Igγ-1 链 C 区(IGHG1)在人胰腺癌细胞中的表达情况,并确定 IGHG1 表达在免疫逃逸机制中的生物学功能。

方法

采用比较蛋白质组学分析方法检测人胰腺癌细胞组织与相邻非癌组织中 IGHG1 的差异表达,随后进行定量实时逆转录-聚合酶链反应、Western blot 分析、免疫组织化学和免疫荧光验证。通过移植过表达 IGHG1 的 Panc02 细胞建立小鼠胰腺肿瘤模型。采用乳酸脱氢酶释放法评估自然杀伤(NK)细胞的细胞毒性反应。

结果

在人胰腺癌细胞组织中发现存在 Igγ-1 链 C 区,但在相邻非癌组织中几乎不存在或表达水平较低。在小鼠胰腺肿瘤模型中,自肿瘤注射后第 12 天至第 20 天,肿瘤生长明显加快,动物的生存时间缩短。阻断 IGHG1 导致肿瘤生长减缓,生存时间延长。细胞毒性测定显示,IGHG1 通过抑制抗体依赖的细胞毒性功能下调 NK 细胞的细胞毒性活性。

结论

IGHG1 在胰腺癌细胞中的存在可能构成肿瘤细胞增殖和免疫逃逸机制的重要因素。

相似文献

1
The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms.IGHG1 在人类胰腺癌中的存在与免疫逃逸机制有关。
Pancreas. 2011 Jul;40(5):753-61. doi: 10.1097/MPA.0b013e318213d51b.
2
Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.用白细胞介素-2基因转导的肿瘤细胞进行特异性主动免疫治疗后对已形成的胰腺癌的抑制作用。
Cancer Gene Ther. 1997 Mar-Apr;4(2):97-104.
3
Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.一种针对GD2神经节苷脂抗原的新型小鼠/人嵌合抗体的结合活性和抗肿瘤特性。
Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5613s-5620s. doi: 10.1158/1078-0432.CCR-07-1057.
4
Pancreas carcinoma antigen fused to invariant chain elicits T-cell response and tumor growth inhibition.与恒定链融合的胰腺癌抗原引发T细胞反应并抑制肿瘤生长。
Pancreas. 2008 Oct;37(3):321-7. doi: 10.1097/MPA.0b013e318166722e7.
5
Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo.用嵌合免疫球蛋白T细胞受体基因修饰的人自然杀伤细胞系可在体内抑制肿瘤生长。
Cancer Gene Ther. 2002 Apr;9(4):390-8. doi: 10.1038/sj.cgt.7700453.
6
Chimeric anti-ganglioside GM2 antibody with antitumor activity.具有抗肿瘤活性的嵌合抗神经节苷脂GM2抗体。
Cancer Res. 1994 Mar 15;54(6):1511-6.
7
Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.肿瘤内皮在人胰腺癌CD4 + CD25 +调节性T细胞浸润中的作用
J Natl Cancer Inst. 2007 Aug 1;99(15):1188-99. doi: 10.1093/jnci/djm064. Epub 2007 Jul 24.
8
Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer.肿瘤相关黏蛋白 MUC5AC 刺激人胰腺癌细胞在体内的致瘤性。
Int J Oncol. 2011 Mar;38(3):619-27. doi: 10.3892/ijo.2011.911. Epub 2011 Jan 18.
9
Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.在胰腺癌中,通过树突状细胞融合杂交体与调节性T细胞耗竭相结合的方式,高水平的Th1和Th17增强抗肿瘤免疫。
Oncol Rep. 2009 Aug;22(2):337-43.
10
Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.原位人胰腺癌异种移植中对抗血管内皮生长因子抗体的不同血管和转录反应
Clin Cancer Res. 2003 Sep 15;9(11):4221-6.

引用本文的文献

1
Identification of proteomic markers of chronic prostatitis/chronic pelvic pain syndrome treated with melatonin using a tandem mass tag approach.采用串联质谱标签法鉴定褪黑素治疗慢性前列腺炎/慢性盆腔疼痛综合征的蛋白质组学标志物。
Curr Urol. 2025 Sep;19(5):331-342. doi: 10.1097/CU9.0000000000000280. Epub 2025 Mar 21.
2
Investigating the potential role of EIF2S2 in OSCC progression through comprehensive bioinformatics analysis and experimental validation.通过全面的生物信息学分析和实验验证来研究真核生物翻译起始因子2亚基2(EIF2S2)在口腔鳞状细胞癌(OSCC)进展中的潜在作用。
Eur J Med Res. 2025 Jul 2;30(1):562. doi: 10.1186/s40001-025-02830-x.
3
Transcriptomic and miRNA Signatures of ChAdOx1 nCoV-19 Vaccine Response Using Machine Learning.
使用机器学习的ChAdOx1 nCoV-19疫苗反应的转录组学和miRNA特征
Life (Basel). 2025 Jun 18;15(6):981. doi: 10.3390/life15060981.
4
Current status and future prospects of cancer-derived immunoglobulins in pancreatic cancer.胰腺癌中癌症衍生免疫球蛋白的现状与未来前景
J Cancer. 2025 Jun 12;16(8):2673-2679. doi: 10.7150/jca.109497. eCollection 2025.
5
Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer.先天性免疫与血小板:揭示它们在慢性胰腺炎和胰腺癌中的作用
Cancers (Basel). 2025 May 17;17(10):1689. doi: 10.3390/cancers17101689.
6
Drug Repurposing to Inhibit Oncostatin M in Crohn's Disease.药物再利用以抑制克罗恩病中的制瘤素M
Molecules. 2025 Apr 24;30(9):1897. doi: 10.3390/molecules30091897.
7
Cancer-Derived Immunoglobulin G and Pancreatic Cancer.癌源性免疫球蛋白 G 与胰腺癌。
Adv Exp Med Biol. 2024;1445:129-135. doi: 10.1007/978-981-97-0511-5_10.
8
Comparison of Non B-Ig and B-Ig.非 B-Ig 与 B-Ig 的比较。
Adv Exp Med Biol. 2024;1445:73-88. doi: 10.1007/978-981-97-0511-5_6.
9
The Expression of Non B Cell-Derived Immunoglobulins.非 B 细胞来源免疫球蛋白的表达。
Adv Exp Med Biol. 2024;1445:11-36. doi: 10.1007/978-981-97-0511-5_2.
10
Current and future immunotherapeutic approaches in pancreatic cancer treatment.当前和未来在胰腺癌治疗中的免疫治疗方法。
J Hematol Oncol. 2024 Jun 4;17(1):40. doi: 10.1186/s13045-024-01561-6.